About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
277 library items
in Leukaemia
Filter results by:
Date Published
2012 (20)
2011 (40)
2010 (56)
2009 (54)
2008 (46)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Leukaemia (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 277
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Clofarabine plus cytarabine vs. cytarabine alone in older patients with relapsed or refractory AML: Results from the CLASSIC I trial
Source:
Journal of Clinical Oncology
,
Date published:
16/05/2012
Category:
8.1.3 Antimetabolites
|
Leukaemia
NeLM
Area:
News
Abstract
2.
NHS HTA: Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia
Source:
No information given
,
Date published:
09/05/2012
Category:
8.1.5 Other antineoplastic drugs
|
Leukaemia
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
3.
NHS HTA: Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia
Source:
NHS HTA
,
Date published:
09/05/2012
Category:
8.1.5 Other antineoplastic drugs
|
Leukaemia
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
4.
Horizon scanning: Vosaroxin granted orphan drug designation for AML
Source:
BioSpace
,
Date published:
04/05/2012
Category:
8.1.5 Other antineoplastic drugs
|
Leukaemia
|
New drugs
NeLM
Area:
News
Link
5.
Costing statement for NICE guidance on dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of CML
Source:
NICE
,
Date published:
25/04/2012
Category:
8.1.5 Other antineoplastic drugs
|
Clinical guidelines
|
Leukaemia
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
News
Link to costing statement
Link to guidance (TA 251)
6.
NICE issues final guidance on dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of CML
Source:
NICE
,
Date published:
25/04/2012
Category:
8.1.5 Other antineoplastic drugs
|
Clinical guidelines
|
Leukaemia
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
Evidence
>
Guidelines
Link to guidance (TA 251)
7.
Phase III study shows cladribine added to daunorubicin and cytarabine during induction results in improved survival in AML patients
Source:
JCO
,
Date published:
17/04/2012
Category:
8.1.3 Antimetabolites
|
Leukaemia
NeLM
Area:
News
Abstract
8.
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): RCT
Source:
Lancet
,
Date published:
05/04/2012
Category:
8.2.4 Other immunomodulating drugs
|
Leukaemia
NeLM
Area:
News
Abstract
Comment
9.
Long-term follow-up of patients treated with imatinib mesylate therapy for chronic phase chronic myeloid leukaemia after failure of interferon alpha therapy
Source:
Cancer
,
Date published:
05/04/2012
Category:
8.1.5 Other antineoplastic drugs
|
Leukaemia
NeLM
Area:
News
Abstract
10.
Dasatinib associated with isolated cases of pre-capillary pulmonary hypertension?
Source:
Circulation
,
Date published:
03/04/2012
Category:
8.1.5 Other antineoplastic drugs
|
Adverse Drug Reactions
|
Leukaemia
NeLM
Area:
News
Abstract
Results 1 - 10 of 277
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next